|
|
|
|
||
Re: Sanofi $SNY points out $SGMO Sangamo Zink Finger Gene Editing @ BoafAML John C. Reed - - Executive VP and Global Head of Research & Development says would like to accelerate the gene therapy aspiration; interested in expanding that into other venuesBasically, anything not approved is considered exploratory so I wouldn’t read anything into that statement. Sanofi is a $119B joke. |
return to message board, top of board |